Aristaless-related proteins are structurally de®ned by the presence of a paired-type homeodomain and an additional conserved domain, known as aristaless domain or OAR-domain. These proteins can be further categorized in three groups (Int. J. Dev. Biol., 43 (1999) 651). Group-I aristaless-related genes are linked to functions in the development of the craniofacial and appendicular skeleton and are expressed predominantly in the mesenchyme in stages from gastrulation through at least mid-gestation (Mech. Dev., 48 (1994) 245; Mech. Dev., 52 (1995) 51; Development, 124 (1997) 3999; Dev. Biol., 199 (1998) 11; Development, 126 (1999) 495). In view of the highly redundant character of the functions of these genes in patterning craniofacial and limb structures, we found it important to directly compare their expression patterns at critical stages of craniofacial and limb development. q
Results

Craniofacial regions
At E9.5, Alx3, Alx4 and Cart1 are highly expressed in the frontonasal process mesenchyme underlying the nasal placodes, Cart1 expression extending more ventrally (see arrows Fig. 1A ,E,I and Fig. 2A±C ). At E10.5 and E11.0 they are expressed in the lateral and medial nasal process mesenchyme (see Figs. 1B±D, F±H, J±L and 2K±M) , while Cart1 expression is excluded from a dorsal region in the nasal processes (circle in Fig. 1L ).
From E9.5 to E11.0, Alx3, Alx4 and Cart1 are expressed in the distal mandibular arch (see Figs. 1B,C,F,G,J,K and 2K±M,, Alx4 expression extending more proximally and Cart1 being expressed in a more oral domain (see Fig.  1G ,K). Only Alx4 and Cart1 are expressed in the distal tips of the maxillary process (arrows in Fig. 1F ,J).
Prx1 and Prx2 are also expressed in craniofacial primordia but, compared to Alx3, Alx4 and Cart1, at a lower level in the frontonasal processes (see arrows in Fig. 1N ,R) and stronger in the mandibular and hyoid arch mesenchyme.
Prx1 is expressed in the frontonasal process in a continuous domain, while Prx2 expression is interrupted in the extreme dorsal mesenchyme (circles in Fig. 1S ,T). Prx1 and -2 are strongly expressed in the mesenchyme of the mandibular and hyoid arches, except in the most proximal regions in E9.5±E11.0 mouse embryos (see Fig. 1M±T ). In addition, the expressions of Prx1 and Prx2 were detected in the otocyst (arrowheads in Fig. 1N,R) .
At E9.5, the expression of Prx3 was very low in the mesenchyme of the frontonasal processes and undetectable in the branchial arches (see Fig. 1U ). At E10.5 and E11.0, the Prx3 was detected in the medial nasal processes, proximally in the maxillary process and mandibular arch, and also in the cranial ganglia and the midbrain (see Fig. 1V±X ).
Limbs
In E9.5 mouse embryos, the forelimbs have begun to grow out, but the hindlimb buds are only just recognizable. At E9.5, Alx3, Alx4 and Cart1 are expressed in the mesenchyme of the presumptive hindlimb buds and in the forelimb buds (see Fig. 3A±C ,G±I,Y). In the presumptive hindlimb buds, Alx3 and Alx4 expressions appear to be restricted to more anterior regions, whereas Cart1 expression is visible throughout (see Fig. 3A±C ,Y). Alx3 and Alx4 are expressed anteriorly in E9.5 forelimb bud mesenchyme (see Figs. 2F, G and 3G, H, Y) . Alx3 is also expressed proximally in the posterior forelimb mesenchyme and in the¯ank. Interestingly, in contrast to the published results (Zhao et al., 1994 (Zhao et al., , 1996 , we do detect Cart1 expression in the early limb bud. Expression was found proximally in both anterior and (01)00450-6 www.elsevier.com/locate/modo posterior E9.5 limb bud mesenchyme (arrows in Fig. 3I ). The Cart1 expression in the anterior limb bud mesenchyme may explain the enhanced polydactyly in Alx4/Cart1 double mutants (Qu et al., 1999) . In E10.5 limb buds, Alx3 and Alx4 Fig. 1 . Expression of Alx3, Alx4, Cart1 and Prx1±3 in whole mount E9.5±E11.0 mouse embryos. The ®rst column shows semilateral views on E9.5 embryos, the second column shows the lateral views on E10.5 embryos, the third column shows the frontal views on E10.5 embryos and the fourth column shows the frontal views on E11.0 embryos. Subsequent rows show expression patterns of Alx3, Alx4, Cart1, Prx1, Prx2 and Prx3, respectively. Diagrams illustrate crucial structures during craniofacial development in E9.5 and E10.5 mouse embryos. Caudal ends of E10.5 and E11.0 embryos were removed to allow free view on craniofacial regions. Arrows in (A,E,I) point towards the expressions of Alx3, Alx4 and Cart1, respectively, in the mesenchyme underlying nasal placodes. Arrows in (F,J) show expressions of Alx4 and Cart1, respectively, in the maxillary process. Arrows in (N,R) point towards the expressions of Prx1 and Prx2, respectively, in the nasal processes. Arrowheads in (N,R) point towards expressions of Prx1 and Prx2, respectively, in otocyst. Circles in (L,S,T) show the region of nasal process mesenchyme from which expressions of Cart1 and Prx2, respectively, are excluded. Staining in dorsal regions of the hindbrain as observed in (D) should be considered as an artefact. Note expression of Prx3 in mesencephalon in panel (V) and trigeminal and facio-acoustic complex in panel (X). Abbreviations: FNP, frontonasal process; He, heart; LNP, lateral nasal process; Mn, mandibular arch; MNP, medial nasal process; Mx, maxillary process; O, otocyst; St, stomodaeum; 2nd, 2nd branchial arch.
are expressed anteriorly and Cart1, barely detectably, both posteriorly and anteriorly (Figs. 2P and 3S±U, Y) .
Prx1 and Prx2 are also expressed at E9.5 both in fore-and presumptive hindlimb bud mesenchyme in a broad region along the limb margin (see Fig. 3D ,E,J,K,Y). In the forelimb buds, expression is graded at this stage and at E10.5, with highest levels nearer to the epithelium (see Fig.  3P ,Q,V,W,Y).
The expression patterns of Prx1 and Prx2 overlap with, but are considerably different compared to those of Alx3, Alx4 and Cart1. The shortening of the zeugopod in Prx mutants (Ten Berge et al., 1998b; Lu et al., 1999) should be attributed to a defect in the cartilage growth and differentiation, when Prx1 and Prx2 are expressed at E12.5 in the mesenchyme surrounding condensations and at E14.5 in the perichondrium (see Fig. 4 ).
The Prx3 expression is at E9.5, detected only in the forelimb bud (see Fig. 3F ,L,Y) in a pattern nearly complementary to that of Prx1 and Prx2 at that stage, since it is excluded from the most distal limb margin and highly expressed in more proximal areas. At E10.5, Prx3 is expressed both in fore-and hindlimbs in a similar pattern as in the E9.5 forelimb buds, but now expression seems to be down-regulated in a proximo-anterior region where Alx3, Alx4 and Cart1 are expressed (see Fig. 3R ,X,Y).
Conclusions
The expression patterns described suggest a classi®cation of the aristaless-related group-I genes in three subgroups, which is consistent with the similarities in the gene structure and results from functional studies as far as available. One group consists of Alx3, Alx4 and Cart1, another of Prx1 and Prx2 and the last of Prx3.
Experimental procedures
Embryos and in situ hybridization
All procedures were carried out as described in Leussink et al. (1995) and Ten Berge et al (1998a,b) . All animal experiments were conducted under the approval of the animal care committee of the KNAW (Royal Dutch Academy of Arts and Sciences).
Probes
Alx3, Cart1, Prx1 and Prx2: see Leussink et al. (1995) and Ten Berge et al (1998a,b) . Alx4: a plasmid containing 0.6 kb Alx4 cDNA was cut with EcoRV and transcribed with T7 polymerase. Prx3: a vector containing 220 bp rat Prx3A cDNA was cut with HindIII and transcribed with T3 RNA polymerase. F., 1998a. Mouse Alx3: an aristaless-like homeobox gene expressed during embryogenesis in ectomesenchyme and lateral plate mesoderm. Dev. Biol. 199, 11±25. Ten Berge, D., Brouwer, A., Korving, J., Martin, J.F., Meijlink, F., 1998b.
Prx1 and Prx2 in skeletogenesis: roles in the craniofacial region, inner ear and limbs. Development 125, 3831±3842. Zhao, G.Q., Eberspaecher, H., Seldin, M.F., deCrombrugghe, B., 1994. The gene for the homeodomain-containing protein Cart-1 is expressed in cells that have a chondrogenic potential during embryonic development. Mech. Dev. 48, 245±254. Zhao, Q., Behringer, R.R., DeCrombrugghe, B., 1996. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene. Nat. Genet. 13, 275±283.
